世界のイプラトロピウムブロマイド市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ipratropium Bromide Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3277
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、イプラトロピウムブロマイドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（溶液、ガス（粉末）ミスト）、用途別市場規模（慢性閉塞性肺疾患、喘息、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・イプラトロピウムブロマイドの市場動向
・企業の競争状況、市場シェア
・イプラトロピウムブロマイドの種類別市場規模（溶液、ガス（粉末）ミスト）
・イプラトロピウムブロマイドの用途別市場規模（慢性閉塞性肺疾患、喘息、その他）
・イプラトロピウムブロマイドの北米市場規模2016-2027（アメリカ、カナダ）
・イプラトロピウムブロマイドのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・イプラトロピウムブロマイドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・イプラトロピウムブロマイドの中南米市場規模2016-2027（メキシコ、ブラジル）
・イプラトロピウムブロマイドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Boehringer Ingelheim、Nektar Therapeutics、Synthetic Biologics、AstraZeneca、Synapse Pharma、Vectura Group、Elan、RPK Pharma、Apotex Corporation、Dominion Pharmacal (Teva)、Mylan Pharmaceuticals、Shandong Jingwei Pharmaceutical、Shenzhen Taitai Pharmaceutical、Beijing Haidrun Pharmaceutical Group）
・結論

Market Analysis and Insights: Global Ipratropium Bromide Market
The global Ipratropium Bromide market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ipratropium Bromide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ipratropium Bromide market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ipratropium Bromide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ipratropium Bromide market.

Global Ipratropium Bromide Scope and Market Size
Ipratropium Bromide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ipratropium Bromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Solution
Gas (Powder) Mist

Segment by Application
Chronic Obstructive Pulmonary Disease
Asthma
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim
Nektar Therapeutics
Synthetic Biologics
AstraZeneca
Synapse Pharma
Vectura Group
Elan
RPK Pharma
Apotex Corporation
Dominion Pharmacal (Teva)
Mylan Pharmaceuticals
Shandong Jingwei Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ipratropium Bromide Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Solution
1.2.3 Gas (Powder) Mist
1.3 Market by Application
1.3.1 Global Ipratropium Bromide Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chronic Obstructive Pulmonary Disease
1.3.3 Asthma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ipratropium Bromide Market Perspective (2016-2027)
2.2 Ipratropium Bromide Growth Trends by Regions
2.2.1 Ipratropium Bromide Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ipratropium Bromide Historic Market Share by Regions (2016-2021)
2.2.3 Ipratropium Bromide Forecasted Market Size by Regions (2022-2027)
2.3 Ipratropium Bromide Industry Dynamic
2.3.1 Ipratropium Bromide Market Trends
2.3.2 Ipratropium Bromide Market Drivers
2.3.3 Ipratropium Bromide Market Challenges
2.3.4 Ipratropium Bromide Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ipratropium Bromide Players by Revenue
3.1.1 Global Top Ipratropium Bromide Players by Revenue (2016-2021)
3.1.2 Global Ipratropium Bromide Revenue Market Share by Players (2016-2021)
3.2 Global Ipratropium Bromide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ipratropium Bromide Revenue
3.4 Global Ipratropium Bromide Market Concentration Ratio
3.4.1 Global Ipratropium Bromide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ipratropium Bromide Revenue in 2020
3.5 Ipratropium Bromide Key Players Head office and Area Served
3.6 Key Players Ipratropium Bromide Product Solution and Service
3.7 Date of Enter into Ipratropium Bromide Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ipratropium Bromide Breakdown Data by Type
4.1 Global Ipratropium Bromide Historic Market Size by Type (2016-2021)
4.2 Global Ipratropium Bromide Forecasted Market Size by Type (2022-2027)

5 Ipratropium Bromide Breakdown Data by Application
5.1 Global Ipratropium Bromide Historic Market Size by Application (2016-2021)
5.2 Global Ipratropium Bromide Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ipratropium Bromide Market Size (2016-2027)
6.2 North America Ipratropium Bromide Market Size by Type
6.2.1 North America Ipratropium Bromide Market Size by Type (2016-2021)
6.2.2 North America Ipratropium Bromide Market Size by Type (2022-2027)
6.2.3 North America Ipratropium Bromide Market Size by Type (2016-2027)
6.3 North America Ipratropium Bromide Market Size by Application
6.3.1 North America Ipratropium Bromide Market Size by Application (2016-2021)
6.3.2 North America Ipratropium Bromide Market Size by Application (2022-2027)
6.3.3 North America Ipratropium Bromide Market Size by Application (2016-2027)
6.4 North America Ipratropium Bromide Market Size by Country
6.4.1 North America Ipratropium Bromide Market Size by Country (2016-2021)
6.4.2 North America Ipratropium Bromide Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ipratropium Bromide Market Size (2016-2027)
7.2 Europe Ipratropium Bromide Market Size by Type
7.2.1 Europe Ipratropium Bromide Market Size by Type (2016-2021)
7.2.2 Europe Ipratropium Bromide Market Size by Type (2022-2027)
7.2.3 Europe Ipratropium Bromide Market Size by Type (2016-2027)
7.3 Europe Ipratropium Bromide Market Size by Application
7.3.1 Europe Ipratropium Bromide Market Size by Application (2016-2021)
7.3.2 Europe Ipratropium Bromide Market Size by Application (2022-2027)
7.3.3 Europe Ipratropium Bromide Market Size by Application (2016-2027)
7.4 Europe Ipratropium Bromide Market Size by Country
7.4.1 Europe Ipratropium Bromide Market Size by Country (2016-2021)
7.4.2 Europe Ipratropium Bromide Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ipratropium Bromide Market Size (2016-2027)
8.2 Asia-Pacific Ipratropium Bromide Market Size by Type
8.2.1 Asia-Pacific Ipratropium Bromide Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ipratropium Bromide Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ipratropium Bromide Market Size by Type (2016-2027)
8.3 Asia-Pacific Ipratropium Bromide Market Size by Application
8.3.1 Asia-Pacific Ipratropium Bromide Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ipratropium Bromide Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ipratropium Bromide Market Size by Application (2016-2027)
8.4 Asia-Pacific Ipratropium Bromide Market Size by Region
8.4.1 Asia-Pacific Ipratropium Bromide Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ipratropium Bromide Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ipratropium Bromide Market Size (2016-2027)
9.2 Latin America Ipratropium Bromide Market Size by Type
9.2.1 Latin America Ipratropium Bromide Market Size by Type (2016-2021)
9.2.2 Latin America Ipratropium Bromide Market Size by Type (2022-2027)
9.2.3 Latin America Ipratropium Bromide Market Size by Type (2016-2027)
9.3 Latin America Ipratropium Bromide Market Size by Application
9.3.1 Latin America Ipratropium Bromide Market Size by Application (2016-2021)
9.3.2 Latin America Ipratropium Bromide Market Size by Application (2022-2027)
9.3.3 Latin America Ipratropium Bromide Market Size by Application (2016-2027)
9.4 Latin America Ipratropium Bromide Market Size by Country
9.4.1 Latin America Ipratropium Bromide Market Size by Country (2016-2021)
9.4.2 Latin America Ipratropium Bromide Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ipratropium Bromide Market Size (2016-2027)
10.2 Middle East & Africa Ipratropium Bromide Market Size by Type
10.2.1 Middle East & Africa Ipratropium Bromide Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ipratropium Bromide Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ipratropium Bromide Market Size by Type (2016-2027)
10.3 Middle East & Africa Ipratropium Bromide Market Size by Application
10.3.1 Middle East & Africa Ipratropium Bromide Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ipratropium Bromide Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ipratropium Bromide Market Size by Application (2016-2027)
10.4 Middle East & Africa Ipratropium Bromide Market Size by Country
10.4.1 Middle East & Africa Ipratropium Bromide Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ipratropium Bromide Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Ipratropium Bromide Introduction
11.1.4 Boehringer Ingelheim Revenue in Ipratropium Bromide Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Nektar Therapeutics
11.2.1 Nektar Therapeutics Company Details
11.2.2 Nektar Therapeutics Business Overview
11.2.3 Nektar Therapeutics Ipratropium Bromide Introduction
11.2.4 Nektar Therapeutics Revenue in Ipratropium Bromide Business (2016-2021)
11.2.5 Nektar Therapeutics Recent Development
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Details
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Ipratropium Bromide Introduction
11.3.4 Synthetic Biologics Revenue in Ipratropium Bromide Business (2016-2021)
11.3.5 Synthetic Biologics Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Ipratropium Bromide Introduction
11.4.4 AstraZeneca Revenue in Ipratropium Bromide Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Synapse Pharma
11.5.1 Synapse Pharma Company Details
11.5.2 Synapse Pharma Business Overview
11.5.3 Synapse Pharma Ipratropium Bromide Introduction
11.5.4 Synapse Pharma Revenue in Ipratropium Bromide Business (2016-2021)
11.5.5 Synapse Pharma Recent Development
11.6 Vectura Group
11.6.1 Vectura Group Company Details
11.6.2 Vectura Group Business Overview
11.6.3 Vectura Group Ipratropium Bromide Introduction
11.6.4 Vectura Group Revenue in Ipratropium Bromide Business (2016-2021)
11.6.5 Vectura Group Recent Development
11.7 Elan
11.7.1 Elan Company Details
11.7.2 Elan Business Overview
11.7.3 Elan Ipratropium Bromide Introduction
11.7.4 Elan Revenue in Ipratropium Bromide Business (2016-2021)
11.7.5 Elan Recent Development
11.8 RPK Pharma
11.8.1 RPK Pharma Company Details
11.8.2 RPK Pharma Business Overview
11.8.3 RPK Pharma Ipratropium Bromide Introduction
11.8.4 RPK Pharma Revenue in Ipratropium Bromide Business (2016-2021)
11.8.5 RPK Pharma Recent Development
11.9 Apotex Corporation
11.9.1 Apotex Corporation Company Details
11.9.2 Apotex Corporation Business Overview
11.9.3 Apotex Corporation Ipratropium Bromide Introduction
11.9.4 Apotex Corporation Revenue in Ipratropium Bromide Business (2016-2021)
11.9.5 Apotex Corporation Recent Development
11.10 Dominion Pharmacal (Teva)
11.10.1 Dominion Pharmacal (Teva) Company Details
11.10.2 Dominion Pharmacal (Teva) Business Overview
11.10.3 Dominion Pharmacal (Teva) Ipratropium Bromide Introduction
11.10.4 Dominion Pharmacal (Teva) Revenue in Ipratropium Bromide Business (2016-2021)
11.10.5 Dominion Pharmacal (Teva) Recent Development
11.11 Mylan Pharmaceuticals
11.11.1 Mylan Pharmaceuticals Company Details
11.11.2 Mylan Pharmaceuticals Business Overview
11.11.3 Mylan Pharmaceuticals Ipratropium Bromide Introduction
11.11.4 Mylan Pharmaceuticals Revenue in Ipratropium Bromide Business (2016-2021)
11.11.5 Mylan Pharmaceuticals Recent Development
11.12 Shandong Jingwei Pharmaceutical
11.12.1 Shandong Jingwei Pharmaceutical Company Details
11.12.2 Shandong Jingwei Pharmaceutical Business Overview
11.12.3 Shandong Jingwei Pharmaceutical Ipratropium Bromide Introduction
11.12.4 Shandong Jingwei Pharmaceutical Revenue in Ipratropium Bromide Business (2016-2021)
11.12.5 Shandong Jingwei Pharmaceutical Recent Development
11.13 Shenzhen Taitai Pharmaceutical
11.13.1 Shenzhen Taitai Pharmaceutical Company Details
11.13.2 Shenzhen Taitai Pharmaceutical Business Overview
11.13.3 Shenzhen Taitai Pharmaceutical Ipratropium Bromide Introduction
11.13.4 Shenzhen Taitai Pharmaceutical Revenue in Ipratropium Bromide Business (2016-2021)
11.13.5 Shenzhen Taitai Pharmaceutical Recent Development
11.14 Beijing Haidrun Pharmaceutical Group
11.14.1 Beijing Haidrun Pharmaceutical Group Company Details
11.14.2 Beijing Haidrun Pharmaceutical Group Business Overview
11.14.3 Beijing Haidrun Pharmaceutical Group Ipratropium Bromide Introduction
11.14.4 Beijing Haidrun Pharmaceutical Group Revenue in Ipratropium Bromide Business (2016-2021)
11.14.5 Beijing Haidrun Pharmaceutical Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ipratropium Bromide Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Solution
Table 3. Key Players of Gas (Powder) Mist
Table 4. Global Ipratropium Bromide Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Ipratropium Bromide Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ipratropium Bromide Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Ipratropium Bromide Market Share by Regions (2016-2021)
Table 8. Global Ipratropium Bromide Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Ipratropium Bromide Market Share by Regions (2022-2027)
Table 10. Ipratropium Bromide Market Trends
Table 11. Ipratropium Bromide Market Drivers
Table 12. Ipratropium Bromide Market Challenges
Table 13. Ipratropium Bromide Market Restraints
Table 14. Global Ipratropium Bromide Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Ipratropium Bromide Market Share by Players (2016-2021)
Table 16. Global Top Ipratropium Bromide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ipratropium Bromide as of 2020)
Table 17. Ranking of Global Top Ipratropium Bromide Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Ipratropium Bromide Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ipratropium Bromide Product Solution and Service
Table 21. Date of Enter into Ipratropium Bromide Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ipratropium Bromide Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Ipratropium Bromide Revenue Market Share by Type (2016-2021)
Table 25. Global Ipratropium Bromide Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Ipratropium Bromide Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Ipratropium Bromide Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Ipratropium Bromide Revenue Market Share by Application (2016-2021)
Table 29. Global Ipratropium Bromide Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Ipratropium Bromide Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Ipratropium Bromide Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Ipratropium Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Ipratropium Bromide Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Ipratropium Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Ipratropium Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Ipratropium Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Ipratropium Bromide Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Ipratropium Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Ipratropium Bromide Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Ipratropium Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Ipratropium Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Ipratropium Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Ipratropium Bromide Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Ipratropium Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ipratropium Bromide Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ipratropium Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ipratropium Bromide Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Ipratropium Bromide Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Ipratropium Bromide Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Ipratropium Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Ipratropium Bromide Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Ipratropium Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Ipratropium Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Ipratropium Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Ipratropium Bromide Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Ipratropium Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ipratropium Bromide Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ipratropium Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ipratropium Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Ipratropium Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 61. Boehringer Ingelheim Company Details
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Ipratropium Bromide Product
Table 64. Boehringer Ingelheim Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Nektar Therapeutics Company Details
Table 67. Nektar Therapeutics Business Overview
Table 68. Nektar Therapeutics Ipratropium Bromide Product
Table 69. Nektar Therapeutics Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 70. Nektar Therapeutics Recent Development
Table 71. Synthetic Biologics Company Details
Table 72. Synthetic Biologics Business Overview
Table 73. Synthetic Biologics Ipratropium Bromide Product
Table 74. Synthetic Biologics Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 75. Synthetic Biologics Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Ipratropium Bromide Product
Table 79. AstraZeneca Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Synapse Pharma Company Details
Table 82. Synapse Pharma Business Overview
Table 83. Synapse Pharma Ipratropium Bromide Product
Table 84. Synapse Pharma Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 85. Synapse Pharma Recent Development
Table 86. Vectura Group Company Details
Table 87. Vectura Group Business Overview
Table 88. Vectura Group Ipratropium Bromide Product
Table 89. Vectura Group Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 90. Vectura Group Recent Development
Table 91. Elan Company Details
Table 92. Elan Business Overview
Table 93. Elan Ipratropium Bromide Product
Table 94. Elan Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 95. Elan Recent Development
Table 96. RPK Pharma Company Details
Table 97. RPK Pharma Business Overview
Table 98. RPK Pharma Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 99. RPK Pharma Recent Development
Table 100. Apotex Corporation Company Details
Table 101. Apotex Corporation Business Overview
Table 102. Apotex Corporation Ipratropium Bromide Product
Table 103. Apotex Corporation Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 104. Apotex Corporation Recent Development
Table 105. Dominion Pharmacal (Teva) Company Details
Table 106. Dominion Pharmacal (Teva) Business Overview
Table 107. Dominion Pharmacal (Teva) Ipratropium Bromide Product
Table 108. Dominion Pharmacal (Teva) Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 109. Dominion Pharmacal (Teva) Recent Development
Table 110. Mylan Pharmaceuticals Company Details
Table 111. Mylan Pharmaceuticals Business Overview
Table 112. Mylan Pharmaceuticals Ipratropium Bromide Product
Table 113. Mylan Pharmaceuticals Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 114. Mylan Pharmaceuticals Recent Development
Table 115. Shandong Jingwei Pharmaceutical Company Details
Table 116. Shandong Jingwei Pharmaceutical Business Overview
Table 117. Shandong Jingwei Pharmaceutical Ipratropium Bromide Product
Table 118. Shandong Jingwei Pharmaceutical Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 119. Shandong Jingwei Pharmaceutical Recent Development
Table 120. Shenzhen Taitai Pharmaceutical Company Details
Table 121. Shenzhen Taitai Pharmaceutical Business Overview
Table 122. Shenzhen Taitai Pharmaceutical Ipratropium Bromide Product
Table 123. Shenzhen Taitai Pharmaceutical Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 124. Shenzhen Taitai Pharmaceutical Recent Development
Table 125. Beijing Haidrun Pharmaceutical Group Company Details
Table 126. Beijing Haidrun Pharmaceutical Group Business Overview
Table 127. Beijing Haidrun Pharmaceutical Group Ipratropium Bromide Product
Table 128. Beijing Haidrun Pharmaceutical Group Revenue in Ipratropium Bromide Business (2016-2021) & (US$ Million)
Table 129. Beijing Haidrun Pharmaceutical Group Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ipratropium Bromide Market Share by Type: 2020 VS 2027
Figure 2. Solution Features
Figure 3. Gas (Powder) Mist Features
Figure 4. Global Ipratropium Bromide Market Share by Application: 2020 VS 2027
Figure 5. Chronic Obstructive Pulmonary Disease Case Studies
Figure 6. Asthma Case Studies
Figure 7. Other Case Studies
Figure 8. Ipratropium Bromide Report Years Considered
Figure 9. Global Ipratropium Bromide Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Ipratropium Bromide Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Ipratropium Bromide Market Share by Regions: 2020 VS 2027
Figure 12. Global Ipratropium Bromide Market Share by Regions (2022-2027)
Figure 13. Global Ipratropium Bromide Market Share by Players in 2020
Figure 14. Global Top Ipratropium Bromide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ipratropium Bromide as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Ipratropium Bromide Revenue in 2020
Figure 16. Global Ipratropium Bromide Revenue Market Share by Type (2016-2021)
Figure 17. Global Ipratropium Bromide Revenue Market Share by Type (2022-2027)
Figure 18. North America Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Ipratropium Bromide Market Share by Type (2016-2027)
Figure 20. North America Ipratropium Bromide Market Share by Application (2016-2027)
Figure 21. North America Ipratropium Bromide Market Share by Country (2016-2027)
Figure 22. United States Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ipratropium Bromide Market Share by Type (2016-2027)
Figure 26. Europe Ipratropium Bromide Market Share by Application (2016-2027)
Figure 27. Europe Ipratropium Bromide Market Share by Country (2016-2027)
Figure 28. Germany Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ipratropium Bromide Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Ipratropium Bromide Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Ipratropium Bromide Market Share by Region (2016-2027)
Figure 38. China Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ipratropium Bromide Market Share by Type (2016-2027)
Figure 46. Latin America Ipratropium Bromide Market Share by Application (2016-2027)
Figure 47. Latin America Ipratropium Bromide Market Share by Country (2016-2027)
Figure 48. Mexico Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ipratropium Bromide Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Ipratropium Bromide Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Ipratropium Bromide Market Share by Country (2016-2027)
Figure 54. Turkey Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Ipratropium Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 58. Nektar Therapeutics Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 59. Synthetic Biologics Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 61. Synapse Pharma Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 62. Vectura Group Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 63. Elan Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 64. RPK Pharma Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 65. Apotex Corporation Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 66. Dominion Pharmacal (Teva) Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 67. Mylan Pharmaceuticals Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 68. Shandong Jingwei Pharmaceutical Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 69. Shenzhen Taitai Pharmaceutical Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 70. Beijing Haidrun Pharmaceutical Group Revenue Growth Rate in Ipratropium Bromide Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界のブチルスコポラミン臭化物市場規模・現状・予測（2021年-2027年）

Global Butylscopolamine Bromide Market Size, Status and Forecast 2021-2027
QYR2104Z1046 2021年4月 97Pages
QYResearch社発行の本調査資料では、ブチルスコポラミン臭化物のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル、筋肉内注射、静脈注射/点滴、坐薬、その他）、用途別市場規模（胃、ガスバリウムハイポグラフィー、腹部CTスキャン、...

世界のブチルスコポラミン臭化物市場規模・現状・予測（2021年-2027年）

世界のQX-314-ブロマイド市場規模・現状・予測（2021年-2027年）

Global QX-314-Bromide Market Size, Status and Forecast 2021-2027
QYR2104Z4889 2021年4月 97Pages
QYResearch社発行の本調査資料では、QX-314-ブロマイドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低純度（97％以上）、純度（97％以上99％以下）、高純度（99％以上）、その他）、用途別市場規模（医療、生物科学研究、その他）...

世界のベクロニウム臭化物市場 2021：企業別、地域別、種類・用途別

Global Vecuronium Bromide Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z14587 2021年4月 108Pages
当調査資料では、ベクロニウム臭化物のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ベクロニウム臭化物の種類別市場規模（≥ 98%、＜ 98%）、用途別市場規模（手術、気管挿管）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア...

世界の臭化ベンザルコニウム市場 2021：企業別、地域別、種類・用途別

Global Benzalkonium Bromide Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z02106 2021年4月 104Pages
当調査資料では、臭化ベンザルコニウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。臭化ベンザルコニウムの種類別市場規模（医療用、工業用）、用途別市場規模（防腐剤、カチオン性界面活性剤、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国...

世界の臭化ロクロニウム市場 2021：企業別、地域別、種類・用途別

Global Rocuronium Bromide Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z12072 2021年4月 101Pages
当調査資料では、臭化ロクロニウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。臭化ロクロニウムの種類別市場規模（≥98％、<98％）、用途別市場規模（麻酔薬、アプリケーション2）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南ア...

イソブチルブロミドの世界市場2020年：分析と予測（～2025年）

iso-Butyl Bromide Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application
MR2104PF425 2021年4月 77Pages
Prof Research社の本調査レポートでは、イソブチルブロミドの世界市場について調査・分析し、イソブチルブロミドのグローバル市場概要、市場動向、産業構造、貿易動向（輸出・輸入）、地域別市場規模（北米、南米、アジア、ヨーロッパ、中東・アフリカ）、世界の市場規模予測、セグメント別分析（用途別（医薬...

臭化リチウムの世界市場2020年：分析と予測（～2025年）

Lithium Bromide Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application
MR2104PF728 2021年4月 83Pages
Prof Research社の本調査レポートでは、臭化リチウムの世界市場について調査・分析し、臭化リチウムのグローバル市場概要、市場動向、産業構造、貿易動向（輸出・輸入）、地域別市場規模（北米、南米、アジア、ヨーロッパ、中東・アフリカ）、世界の市場規模予測、セグメント別分析（用途別（医薬品、タンパク...

世界の医薬品界面活性剤市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Surfactants Market Size, Status and Forecast 2021-2027
QYR2104Z4569 2021年4月 96Pages
QYResearch社発行の本調査資料では、医薬品界面活性剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（陰イオン界面活性剤、陽イオン界面活性剤、両性界面活性剤、非イオン界面活性剤、その他）、用途別市場規模（乳化剤、抗菌剤、プロバイオティクス...

世界の医薬品資産管理市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Asset Managements Market Size, Status and Forecast 2021-2027
QYR2104Z4556 2021年4月 99Pages
QYResearch社発行の本調査資料では、医薬品資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア（製薬資産）、ソフトウェア（製薬資産））、用途別市場規模（医薬品偽造防止、サプライチェーン管理、その他）、主要地域別市場規模（...

世界のQX-314-ブロマイド市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global QX-314-Bromide Market The global QX-314-Bromide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
世界のブチルスコポラミン臭化物市場規模・現状・予測（2021年-2027年） Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication i…
世界のブチルスコポラミン臭化物市場規模・現状・予測（2021年-2027年） Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication i…
世界の慢性閉塞性肺疾患（COPD）治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema characterized by airflow obstruction, which can further develop into a common chronic disease of cor pulmona and respiratory failure.It is related to the abnormal inflammatory reaction of harmful gases and harmful …